Molecular Advances in Gut Microbiota and Intestinal Diseases

Dear Colleagues,

Human intestinal microbiomes have an insurmountable effect on our health status by influencing a wide range of diseases, including cancer, obesity, allergies, and neurological disorders. Food and pharmaceutics industries have been assiduous in providing foods and supplements in order to improve or maintain health and establish a gut microbiota that is regarded as beneficial. Probiotics and prebiotics, postbiotics, and other bioactive compounds may thus benefit our health status in more profound and complex ways. As such, a healthy microbiota may protect us from dysbiosis-related diseases, such as inflammatory bowel disease (IBD) or metabolic disorders. In turn, a resilient dysbiotic microbiota may cause disease. Understanding this intricate network of interactions between microbiota and the host requires a transdisciplinary approach and a greater awareness of the concepts and mechanisms of microbial resilience against dietary, antibiotic, or lifestyle-induced perturbations, which may have grave implications for human health.

This Special Issue invites novel research, reviews, and clinical studies on novel bioactives that induce changes in the cecal microbiota which possess various properties (antioxidant, anti-cancer, and anti-inflammatory), maintain intestinal homeostasis, target metabolic responses in the host, or alleviate the effects of dysbiosis. 

Prof. Dr. Wolfram Manuel Brück
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.